Clinical Trials Logo

Clinical Trial Summary

Fondaparinux is a synthetic antithrombotic agent with specific anti-factor Xa activity. A population pharmacokinetic model of fondaparinux, based on data obtained in patients included in phase II/III trials, has been described. However, the validity of this model in everyday practice needed to be confirmed. This study was a multicenter, prospective cohort study in consecutive orthopedic patients treated with 2.5 mg of fondaparinux. Anti-Xa activities were recorded in 809 patients. Population parameters and inter-individual variability were estimated using NONMEM VI software. A two-compartment model with first-order absorption best described fondaparinux pharmacokinetics. Covariates partly explaining inter-individual variability were body weight, age and creatinine clearance estimated by the simplified Modification of Diet in Renal Disease formula. A body weight less than 50 kg and moderate renal failure increased drug exposure. These results suggest that fondaparinux pharmacokinetics need to be confirmed in patient populations not fully assessed in phase II/III studies


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01063543
Study type Observational
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Completed
Phase N/A
Start date September 2004
Completion date February 2007

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03657368 - Ventilation Strategy During General Anesthesia for Orthopedic Surgery N/A
Withdrawn NCT02771041 - Assessment of the Influence of Early Preoperative Consultation on Satisfaction and the Average Length of Stay of Patients Who Underwent Total Hip Arthroplasty N/A
Completed NCT02278627 - Impact of a Technique of Massage During the First Week of Hospitalization on the Recycling of the Mobility of the Knee Further to the Installation of Knee Replacement N/A
Recruiting NCT01205295 - Patient Anxiety and Concern as Predictors for the Perceived Quality and Efficacy of Treatment N/A
Completed NCT01389011 - Perfusion Index (PI) and Pleth Variability Index (PVI) in Patients With Interscalene Blocks in Orthopedic Surgery N/A
Active, not recruiting NCT03629262 - Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery Phase 4
Not yet recruiting NCT05537155 - Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery N/A
Completed NCT03532256 - Post-op Crowd Sourcing Health Data Via Text-messaging
Active, not recruiting NCT03366805 - A Patient Education Video Program for Post-Operative Recovery After Upper Extremity Surgery N/A
Completed NCT03769077 - Cycle to Fun - 'Exergames' for Inpatient Rehabilitation for Children/Youth With CP N/A
Recruiting NCT05401058 - Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery N/A
Completed NCT00293631 - Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy Phase 2
Completed NCT05110690 - Behavioral Activation and Medication Optimization for Perioperative Mental Health Feasibility Study N/A
Completed NCT05120739 - Efficacy of CHX Cloths Versus CHX Soaps for Bathes Before Orthopedic Surgery N/A
Completed NCT00724035 - Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery Phase 4
Completed NCT00702416 - Ultrasound Guidance for Interscalene Brachial Plexus Block Phase 4
Completed NCT00192894 - New Methods to Detect a Decrease in Heart Function Phase 4
Completed NCT05424211 - The Effect of Music Therapy on Pain Level and Analgesic Consumption N/A
Withdrawn NCT00269971 - A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. Phase 3
Completed NCT03430453 - Monitoring of Intensity of Stimulation and Injection Pressure in US Guided Peripheral Nerve Block According to Anatomic Needle Type Position N/A